Related Experiment Video
Updated: Jan 27, 2026

Validating Whole Genome Nanopore Sequencing, using Usutu Virus as an Example
Published on: March 11, 2020
A case of genotype-3b hepatitis C virus in which the whole genome was successfully analyzed using third-generation
Yoshihito Uchida1, Jun-Ichi Kouyama1, Kayoko Naiki1
1Department of Gastroenterology and Hepatology, Faculty of Medicine, Saitama Medical University, Saitama, Japan.
Insights
MinION nanopore sequencing successfully determined the whole genome of a difficult-to-classify hepatitis C virus (HCV) genotype 3b strain. This advanced sequencing method is valuable for HCV subtyping when standard methods fail.
Area of Science:
- Virology
- Genomics
- Next-Generation Sequencing
Background:
- Chronic hepatitis C virus (HCV) infection requires accurate genotyping for effective antiviral therapy.
- Standard diagnostic kits sometimes fail to subtypify specific HCV genotypes, such as genotype 3.
Observation:
- A 42-year-old Chinese male with chronic HCV infection presented challenges for subgenotype determination using conventional methods.
- Whole-genome sequencing of the HCV strain was performed using the MinION nanopore sequencer.
Findings:
- The MinION platform successfully sequenced 9442 bases of the HCV genome, classifying it as genotype 3b.
- Sequence analysis revealed nucleotide identities of 87.6%–93.9% with known genotype 3b strains.
- No known resistance-associated substitutions in NS3, NS5A, or NS5B were detected in this strain.
Implications:
- The MinION nanopore sequencer offers a viable solution for comprehensive HCV genome analysis, particularly for challenging subgenotypes.
- This technology can aid in understanding HCV diversity and guiding personalized antiviral treatment strategies.
- Improved subtyping capabilities can enhance the management of hepatitis C virus infections globally.
Abstract:
A 42-year-old Chinese man with chronic hepatitis C virus (HCV) infection visited our hospital for antiviral therapy. The subgenotype could not be determined using the HCV GENOTYPE Primer Kit (Institute of Immunology, Tokyo, Japan), which can identify genotype 3a HCV exclusively among genotype 3 HCV. Thus, the whole-genome sequence of HCV was analyzed using the MinION nanopore sequencer (Oxford Nanopore Technologies, Oxford, UK), a third-generation single-molecule sequencing platform. Consequently, a total of 9442 bases with a 73.6 mean depth, corresponding to the sequences between nt25 and PolyU/UC were determined (LC414155.2). The similarity analysis revealed that the obtained sequence was classified into genotype 3b HCV and showed nucleotide identities from 87.6% to 93.9% with those of 12 previously reported strains. Furthermore, possible resistance-associated substitutions in non-structural protein (NS)3, NS5A, and NS5B based on consensus sequences of 12 genotype 3b HCV strains, including NS5A-Y93H and NS5B-S282 T substitutions, were absent. In conclusion, the MinION nanopore sequencer is useful for analyzing the HCV genome, especially the genomes of genotype 3 HCV strains for which standardized real- time PCR methods for all subgenotypes have not been established.
Related Concept Videos
Viruses with RNA Genomes
Genomics
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
What are Viruses?
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Genome Size and the Evolution of New Genes

